Your browser doesn't support javascript.
loading
P300/CBP-associated factor (PCAF)-mediated acetylation of Fascin at lysine 471 inhibits its actin-bundling activity and tumor metastasis in esophageal cancer.
Cheng, Yin-Wei; Zeng, Fa-Min; Li, Da-Jia; Wang, Shao-Hong; He, Jian-Zhong; Guo, Zhen-Chang; Nie, Ping-Juan; Wu, Zhi-Yong; Shi, Wen-Qi; Wen, Bing; Xu, Xiu-E; Liao, Lian-Di; Li, Zhi-Mao; Wu, Jian-Yi; Zhan, Jun; Zhang, Hong-Quan; Chang, Zhi-Jie; Zhang, Kai; Xu, Li-Yan; Li, En-Min.
Affiliation
  • Cheng YW; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Zeng FM; Institute of Basic Medical Science, Cancer Research Center, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Li DJ; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Wang SH; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • He JZ; Shantou Central Hospital, Affiliated Shantou Hospital of Sun Yat-sen University, Shantou, Guangdong, 515041, P. R. China.
  • Guo ZC; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Nie PJ; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Institute of Oncologic Pathology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Wu ZY; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Shi WQ; Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, P. R. China.
  • Wen B; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Xu XE; Shantou Central Hospital, Affiliated Shantou Hospital of Sun Yat-sen University, Shantou, Guangdong, 515041, P. R. China.
  • Liao LD; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Li ZM; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Wu JY; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Zhan J; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Institute of Oncologic Pathology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Zhang HQ; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Chang ZJ; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Institute of Oncologic Pathology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Zhang K; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Xu LY; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Institute of Oncologic Pathology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
  • Li EM; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.
Cancer Commun (Lond) ; 41(12): 1398-1416, 2021 12.
Article de En | MEDLINE | ID: mdl-34555274
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'oesophage / Protéines de transport / Facteurs de transcription CBP-p300 / Carcinome épidermoïde de l'oesophage / Protéines des microfilaments Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Cancer Commun (Lond) Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'oesophage / Protéines de transport / Facteurs de transcription CBP-p300 / Carcinome épidermoïde de l'oesophage / Protéines des microfilaments Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Cancer Commun (Lond) Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique